CAR T cell therapy startup Arsenal Biosciences has reeled in a $325 million Series C as it works through two early-stage ...

A daily injection intended to protect and regenerate brain cells has failed to slow the progression of Alzheimer’s disease in ...

BioAge Labs is heading to Wall Street after months of speculation that the Eli Lilly-partnered cardiometabolic biotech was ...

All doses of Novo Nordisk’s Ozempic are expected to face “intermittent shortages” in Europe during the fourth quarter of the ...

Researchers reported Sunday that atrial fibrillation patients who received Bayer’s experimental anticoagulant were ...

Pfizer and Valneva said patients demonstrated “strong immune responses” after receiving a second booster dose of their ...

Illumina's legal victory against the European Union's antitrust enforcer won't give the testing company back its $7.1 billion ...

Dyne Therapeutics’ new data on its experimental Duchenne muscular dystrophy drug is being overshadowed by the departure of ...

Recursion reported mixed data Tuesday from its first Phase 2 study, in a disappointing start to an expected frenzy of ...

Vaxcyte shares $PCVX jumped more than 35% Tuesday morning on the heels of Phase 1/2 data for its 31-valent pneumococcal ...

PatientPartner, a startup that matches patients with mentors who’ve gone through similar medical treatments, just raised $7 ...

Adaptin Bio is launching with plans to bring a bispecific T cell engager for glioblastoma, a deadly form of brain cancer, ...